• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up 0.41% Nasdaq Up 0.42%

    Dyax Corp. (DYAX)

    -NasdaqGM
    25.53 Up 0.19(0.75%) 1:43PM EDT - Nasdaq Real Time Price
    Add to Portfolio
    Prev Close:25.34
    Open:25.57
    Bid:25.49 x 200
    Ask:25.52 x 300
    1y Target Est:29.75
    Beta:0.73
    Earnings Date:Jul 27 - Jul 31 (Est.)
    Day's Range:25.14 - 25.78
    52wk Range:7.87 - 30.55
    Volume:389,867
    Avg Vol (3m):1,987,580
    Market Cap:3.72B
    P/E (ttm):N/A
    EPS (ttm):-0.10
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    DYAXUp 0.75%3.72B
    SHPGUp 0.07%50.09B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):41.94
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-0.19
    Quarterly EPS Est (Jun-15) :-0.04
    Mean Recommendation*:1.9
    PEG Ratio (5 yr expected):-7.45

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Dyax Corp., a biopharmaceutical company, identifies, develops, and commercializes treatments for hereditary angioedema (HAE) and other plasma-kallikrein-mediated (PKM) disorders. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback